Level D· Scientific groundwork from lab and animal studiesAnimal StudyPubMedOpen access

Fractional carbon dioxide laser-induced photothermal activation of mesenchymal stem cell-derived exosomes accelerates diabetic wound healing by enhancing angiogenesis.

Chen JY., Ji Z., Guo K., Wang HN., Zhu CC., Li T.

Animal Study on Diabetic Foot, Chronic Wound, published in World J Diabetes (2026) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Animal Study
Journal
World J Diabetes (2026)
Country
United States
Reported sample size
—
Source database
PubMed
PMID
41608090
PMCID
PMC12836190
DOI
10.4239/wjd.v17.i1.112942

Abstract (original English)

Background Exosomes (Exos) derived from mesenchymal stem cells (MSCs) have emerged as a promising therapeutic option for diabetic wound healing owing to their strong pro-angiogenic potential. Nevertheless, their relatively low bioactivity remains a major barrier to successful clinical application. Fractional CO 2 laser therapy offers a precise and controllable form of photothermal stimulation that may potentiate exosome activity without the need for additional exogenous agents, possibly promoting more effective diabetic wound repair. Aim To investigate the mechanisms through which low-energy fractional Exos derived from CO 2 laser-preconditioned adipose-derived MSCs (Ad-MSCs) (CO 2 laser-Exos) promote the healing of diabetic wounds. Methods Ad-MSCs were subjected to a single exposure of fractional CO 2 laser at energy densities of 30 mJ/cm 2 , 40 mJ/cm 2 , or 50 mJ/cm 2 . Infrared thermography was employed to monitor temperature fluctuations in the culture medium. To determine the optimal energy level, western blotting was performed to assess heat shock protein 90 expression, while apoptosis was analyzed by flow cytometry. Exos were subsequently isolated through ultracentrifugation, and sphingosine-1-phosphate (S1P) concentrations within the Exos were measured using enzyme-linked immunosorbent assay. The therapeutic efficacy and underlying mechanisms of CO 2 laser-Exos were fur

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research